Effamall Insights More
      China’s Vitamin Market Remains Subdued but Stable Amid Limited Demand and Thin Trading; European Vitamin Market Fluctuates at Low Levels
      China’s Vitamin Market Remains Subdued but Stable Amid Limited Demand and Thin Trading; European Vitamin Market Fluctuates at Low Levels
      Vitamin 11-13 17:20
      China's Amino Acid Market: Prices Steady with Fluctuations, Threonine Quotes Edge Higher amid Subdued Trading; European Prices Remain Weak but Stable
      China's Amino Acid Market: Prices Steady with Fluctuations, Threonine Quotes Edge Higher amid Subdued Trading; European Prices Remain Weak but Stable
      Amino Acid 11-13 17:10
      Dicalcium Phosphate Edges Down Amid Fluctuations;  Sodium Bicarbonate Holds Steady; Whey Powder Remains Steady-to-Firmer
      Dicalcium Phosphate Edges Down Amid Fluctuations; Sodium Bicarbonate Holds Steady; Whey Powder Remains Steady-to-Firmer
      Minerals 11-13 17:01
      Haid Group Posts Q3 2026 Net Profits of RMB 1.296 Billion, Down 13.81% YoY
      Haid Group Posts Q3 2026 Net Profits of RMB 1.296 Billion, Down 13.81% YoY
      Enterprise News 11-12 14:43
      Fengyuan Pharmaceutical Reports Q3 2026 Net Profits of RMB 14.45 Million, Down 39.82% YoY
      Fengyuan Pharmaceutical Reports Q3 2026 Net Profits of RMB 14.45 Million, Down 39.82% YoY
      Enterprise News 11-12 14:42
      DSM-Firmenich Releases Q3 2026 Financial Results
      DSM-Firmenich Releases Q3 2026 Financial Results
      Enterprise News 11-12 14:41
      Dabeinong Technology Reports a Loss of RMB 125 Million in Q3 2026 Net Profits
      Dabeinong Technology Reports a Loss of RMB 125 Million in Q3 2026 Net Profits
      Enterprise News 11-12 14:39
      Minsheng Healthcare Announces Q3 2026 Financial Report
      Minsheng Healthcare Announces Q3 2026 Financial Report
      Enterprise News 11-12 14:38
      Nanjing Red Sun Reports a Net Loss of RMB 38.49 Million in Q3 2026
      Nanjing Red Sun Reports a Net Loss of RMB 38.49 Million in Q3 2026
      Enterprise News 11-12 14:36
      Jingxin Pharmaceutical Reports Q3 2026 Net Profits of RMB 175 Million, Down 6.52% YoY
      Jingxin Pharmaceutical Reports Q3 2026 Net Profits of RMB 175 Million, Down 6.52% YoY
      Enterprise News 11-12 14:35
        All Type
        Loading...
        Loading...